본문

  1. Home
31 Results:SS:PA PP:ELSEVIER INC 0.124 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
Monostotic Paget's disease of the patella
Monostotic Paget's disease of the patella
R. Amr., | Elsevier Inc | 2006 ,
2
Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells
Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells
David J. Rickard., | Elsevier Inc | 2006 ,
3
Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway
Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway
M. Franklin., | Elsevier Inc | 2006 ,
4
Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients
Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients
Helen Tsangari., | Elsevier Inc | 2006 ,
5
Osteoclasts play a part in pain due to the inflammation adjacent to bone
Osteoclasts play a part in pain due to the inflammation adjacent to bone
Maho Nagae., | Elsevier Inc | 2006 ,
6
Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease
Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease
Takayuki Hamano., | Elsevier Inc | 2006 ,
7
PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts
PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts
Jeanne M. Nervina., | Elsevier Inc | 2006 ,
8
Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone
Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone
Heather E. Whitson., | Elsevier Inc | 2006 ,
9
OPG/membranous-RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation
OPG/membranous-RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation
Steeve Kwan Tat., | Elsevier Inc | 2006 ,
10
Treatment of Paget's disease with hypercalcemia
Treatment of Paget's disease with hypercalcemia
Donald H. Gutteridge., | Elsevier Inc | 2006 ,
처음1234이후마지막